Main Article Content
Background: Oral cancer affects millions of people worldwide, which is more common in those 35 and older.
Low-targeted therapy options for oral malignancies and poor drug uptake by lesions in the oral cavity followed
by systemic injection contribute to high mortality and poor patient quality of life. Aim: The present study was
undertaken for optimization and assessment of the designed cisplatin mucoadhesive film made of hydroxyl propyl
methyl cellulose and chitosan that can be used locally to treat oral cancer. Materials and Methods: The films were
prepared by solvent casting method, employing a Box–Behnken design, and subsequently confirmed by ANOVA
analysis. The formulations were optimized by swelling index and residence time. Physiochemical characteristics
of oral films, including pH, weight, thickness, tensile strength, folding endurance, and in vitro drug release, were
also assessed. Results and Discussion: According to the factors selected for the optimization, the formulation
(F3) was selected as the optimized formulation with highest desirability of 0.997. In vitro release profile indicated
initial burst release and subsequently a sustained release of cisplatin from the film for 24 h. The release kinetics
data displayed a Korsmeyer–Peppas release model with the best-fit match R2 value (0.9257). In vitro exposing the
KB-3-1 cell line to the optimized film resulted in dose-dependent cancer cell death. The IC50 of free cisplatin and
cisplatin mucoadhesive film (F3) on KB-3-1 was found to be 94.25 μg/ml and 23.64 μg/ml, respectively. This study
demonstrates that local bioadhesive therapies are effective in treating cancer of the oral cavity. Conclusion: On the
basis of data, it could be concluded that the number of polymers used was the critical factor for the production of
cisplatin mucoadhesive film that had a substantial influence on their physical attributes. This factorial design study
has served as a valuable tool for optimizing mucoadhesive film for the delivery of cisplatin.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.